METHOD FOR INHIBITING ANGIOGENESIS

Details for Australian Patent Application No. 2003217216 (hide)

Owner GENETIX PHARAMACEUTICALS, INC.

Inventors CAO, Yihai; CAO, Renhai; PAWLIUK, Robert; LEBOULCH, Philippe

Pub. Number AU-A-2003217216

PCT Number PCT/US03/01360

PCT Pub. Number WO2003/062788

Priority 60/350,005 17.01.02 US

Filing date 17 January 2003

Wipo publication date 2 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/350,005 17.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003217216

7 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217217-MINIMALLY INVASIVE RETINAL PROSTHESIS

2003217215-METHODS OF RANDOM MUTAGENESIS AND METHODS OF MODIFYING NUCLEIC ACIDS USING TRANSLESION DNA POLYMERASES